Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir

Verfasser / Beitragende:
[S. Yerly, M. Rickenbach, M. Popescu, P. Taffe, C. Craig, L. Perrin]
Ort, Verlag, Jahr:
2001
Enthalten in:
Antiviral Therapy, 6/3(2001-09), 185-189
Format:
Artikel (online)
ID: 439417805